Target intelligence / Profile preview

24-dehydrocholesterol reductase (DHCR24)

Target
DHCR24
Molecular classification
Enzyme, Oxidoreductase
01

Overview

24-Dehydrocholesterol reductase (DHCR24), also known as seladin-1, is a flavin adenine dinucleotide (FAD)-dependent oxidoreductase located in the endoplasmic reticulum. It catalyzes the final step of cholesterol biosynthesis, specifically the reduction of the delta-24 double bond of sterol intermediates, such as the conversion of desmosterol to cholesterol. Beyond its role in lipid metabolism, DHCR24 is involved in protecting cells from oxidative stress and apoptosis, and it plays a critical role in maintaining the integrity of cholesterol-rich membrane microdomains (lipid rafts). Altered expression of DHCR24 is implicated in several pathological conditions; its downregulation is associated with Alzheimer's disease and neurodegeneration, whereas its overexpression is observed in various cancers, including melanoma and adrenal gland cancer. Pharmacological inhibition of DHCR24, using drugs like triparanol or the selective inhibitor SH42, leads to the accumulation of desmosterol, which acts as an endogenous agonist of the liver X receptor (LXR) to promote anti-inflammatory and pro-resolving phenotypes. However, therapeutic targeting of DHCR24 carries significant safety challenges, as complete or systemic inhibition can disrupt cholesterol homeostasis, leading to adverse effects such as cataracts, skin disorders, and developmental abnormalities similar to the genetic disorder desmosterolosis.

Other names
Delta-24-cholesterol reductaseDelta(24)-sterol reductase3-beta-hydroxysterol Delta-24-reductaseSeladin-1Selective AD indicator 1Desmosterol-to-cholesterol enzymeDiminuto/dwarf1 homolog
02

Mechanism of action

Inhibition of 24-dehydrocholesterol reductase (DHCR24) blocks the terminal step of cholesterol biosynthesis, preventing the conversion of desmosterol to cholesterol. This leads to the accumulation of desmosterol, which acts as an endogenous agonist of the liver X receptor (LXR), triggering anti-inflammatory and lipid-reprogramming pathways. Alternatively, in cancer, inhibition of DHCR24 reduces cholesterol levels and disrupts lipid raft formation, thereby suppressing tumor cell proliferation and migration.

03

Biological functions

Cholesterol biosynthesisLipid metabolismApoptosis modulationProtection from oxidative stressNeuronal development and survival
04

Disease associations

Neurodegenerative diseaseCancerInflammationInfectionCardiovascular diseaseOther
05

Safety considerations

Abnormal cholesterol biosynthesisDesmosterol accumulation (desmosterolosis-like symptoms)Neurological development disordersCataracts (as seen with triparanol)AlopeciaSkin disorders (ichthyosis, dryness, peeling)Accelerated atherosclerosis
06

Interacting drugs

Triparanol

4 more in the full profile.

07

Biomarkers

Desmosterol levelsDesmosterol-to-cholesterol ratioLXR target gene expressionAmyloid-beta levelsC-reactive proteinIL-6

Beyond the preview

Go deeper on 24-dehydrocholesterol reductase (DHCR24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 24-dehydrocholesterol reductase (DHCR24).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call